BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14742515)

  • 1. Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya.
    Ohas EA; Adams JH; Waitumbi JN; Orago AS; Barbosa A; Lanar DE; Stoute JA
    Infect Immun; 2004 Feb; 72(2):735-41. PubMed ID: 14742515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.
    Villasis E; Lopez-Perez M; Torres K; Gamboa D; Neyra V; Bendezu J; Tricoche N; Lobo C; Vinetz JM; Lustigman S
    Malar J; 2012 Oct; 11():361. PubMed ID: 23110555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.
    Jakobsen PH; Heegaard PM; Koch C; Wasniowska K; Lemnge MM; Jensen JB; Sim BK
    Infect Immun; 1998 Sep; 66(9):4203-7. PubMed ID: 9712768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
    Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
    Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of functional regions on Plasmodium falciparum EBA-175 by antibodies eluted from immune complexes.
    Sim BK
    Mol Biochem Parasitol; 1998 Sep; 95(2):183-92. PubMed ID: 9803411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids.
    Narum DL; Haynes JD; Fuhrmann S; Moch K; Liang H; Hoffman SL; Sim BK
    Infect Immun; 2000 Apr; 68(4):1964-6. PubMed ID: 10722589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.
    Badiane AS; Bei AK; Ahouidi AD; Patel SD; Salinas N; Ndiaye D; Sarr O; Ndir O; Tolia NH; Mboup S; Duraisingh MT
    Clin Vaccine Immunol; 2013 Aug; 20(8):1238-45. PubMed ID: 23761656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies.
    Daugherty JR; Murphy CI; Doros-Richert LA; Barbosa A; Kashala LO; Ballou WR; Snellings NJ; Ockenhouse CF; Lanar DE
    Infect Immun; 1997 Sep; 65(9):3631-7. PubMed ID: 9284129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
    McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum.
    Okenu DM; Riley EM; Bickle QD; Agomo PU; Barbosa A; Daugherty JR; Lanar DE; Conway DJ
    Infect Immun; 2000 Oct; 68(10):5559-66. PubMed ID: 10992454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.
    Persson KE; McCallum FJ; Reiling L; Lister NA; Stubbs J; Cowman AF; Marsh K; Beeson JG
    J Clin Invest; 2008 Jan; 118(1):342-51. PubMed ID: 18064303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum.
    Healer J; Thompson JK; Riglar DT; Wilson DW; Chiu YH; Miura K; Chen L; Hodder AN; Long CA; Hansen DS; Baum J; Cowman AF
    PLoS One; 2013; 8(9):e72504. PubMed ID: 24039774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Antigens Derived from
    Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderately Neutralizing Epitopes in Nonfunctional Regions Dominate the Antibody Response to
    Salinas ND; Paing MM; Adhikari J; Gross ML; Tolia N
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642904
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
    Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
    Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand.
    Zerka A; Rydzak J; Lass A; Szostakowska B; Nahorski W; Wroczyńska A; Myjak P; Krotkiewski H; Jaskiewicz E
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):149-56. PubMed ID: 26439848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum.
    Touré FS; Deloron P; Migot-Nabias F
    Clin Med Res; 2006 Mar; 4(1):1-6. PubMed ID: 16595787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.
    Persson KE; Fowkes FJ; McCallum FJ; Gicheru N; Reiling L; Richards JS; Wilson DW; Lopaticki S; Cowman AF; Marsh K; Beeson JG
    J Immunol; 2013 Jul; 191(2):785-94. PubMed ID: 23776178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
    Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.